Although not covered in the current investigation, cancer stem cell markers including CD133, CD44, DLK1, and Notch1 as well as the β-catenin/p-GSK3β signaling pathway were significantly down-regulated, and the self-renewal capacity of CSCs was suppressed. The gene discussed is CD44; the disease is cancer.